Novabay Pharmaceuticals Inc Propriété institutionnelle
Quel est le Propriété institutionnelle de Novabay Pharmaceuticals Inc?
Le Propriété institutionnelle de Novabay Pharmaceuticals Inc est 2.57%
Quelle est la définition de Propriété institutionnelle?
La propriété institutionnelle est le montant des actions disponibles d'une société détenues par des fonds mutuels ou des fonds de pension, des compagnies d'assurance, des sociétés d'investissement, des fonds de dotation ou d'autres grandes entités qui gèrent des fonds pour le compte de tiers.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Propriété institutionnelle des entreprises dans Health Care secteur sur NYSEMKT par rapport à Novabay Pharmaceuticals Inc
Que fait Novabay Pharmaceuticals Inc?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Entreprises avec propriété institutionnelle similaire à Novabay Pharmaceuticals Inc
- M.R.M. SA a Propriété institutionnelle de 2.56%
- TINC Comm. VA a Propriété institutionnelle de 2.56%
- Outcrop Gold a Propriété institutionnelle de 2.56%
- iDreamSky Technology a Propriété institutionnelle de 2.56%
- Jaiprakash Power Ventures a Propriété institutionnelle de 2.57%
- Gocl L a Propriété institutionnelle de 2.57%
- Novabay Pharmaceuticals Inc a Propriété institutionnelle de 2.57%
- Kaya a Propriété institutionnelle de 2.57%
- Union Financière de France Banque SA a Propriété institutionnelle de 2.57%
- POET Technologies a Propriété institutionnelle de 2.57%
- iShares ETF (CH) - iShares Core SPI (CH) a Propriété institutionnelle de 2.57%
- Stanley Furniture a Propriété institutionnelle de 2.57%
- River City Bank a Propriété institutionnelle de 2.58%